BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28912398)

  • 1. [Therapeutic Cancer Vaccine and Immune Checkpoint Inhibitor].
    Mimura K; Kono K
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):733-736. PubMed ID: 28912398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
    Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
    Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication.
    Ali OA; Lewin SA; Dranoff G; Mooney DJ
    Cancer Immunol Res; 2016 Feb; 4(2):95-100. PubMed ID: 26669718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges.
    Kyi C; Postow MA
    Immunotherapy; 2016 Jun; 8(7):821-37. PubMed ID: 27349981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are peptide vaccines viable in combination with other cancer immunotherapies?
    Ohtake J; Sasada T
    Future Oncol; 2017 Aug; 13(18):1577-1580. PubMed ID: 28776424
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enhancement of Cytotoxic T Lymphocytes(CTLs)Infiltration into the Cancer Tissues].
    Akazawa Y; Suzuki T; Nakatsura T
    Gan To Kagaku Ryoho; 2018 Feb; 45(2):227-231. PubMed ID: 29483410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adoptive Cell Therapy with Immune Checkpoint Blockade].
    Aruga A
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):737-741. PubMed ID: 28912399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(4):2665-76. PubMed ID: 10953341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic CD8
    Iwahori K
    Adv Exp Med Biol; 2020; 1224():53-62. PubMed ID: 32036604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.
    Gatti-Mays ME; Redman JM; Collins JM; Bilusic M
    Hum Vaccin Immunother; 2017 Nov; 13(11):2561-2574. PubMed ID: 28857666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic Targeting of Cancer Stem Cells.
    Zhang J; Li Q; Chang AE
    Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination Therapy of Immune Checkpoint Inhibitors].
    Kitano S
    Gan To Kagaku Ryoho; 2017 Sep; 44(9):727-732. PubMed ID: 28912397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression.
    Rice AE; Latchman YE; Balint JP; Lee JH; Gabitzsch ES; Jones FR
    Cancer Gene Ther; 2015 Sep; 22(9):454-62. PubMed ID: 26337747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on immunotherapy.
    Weber JS
    Semin Oncol; 2014 Oct; 41 Suppl 5():S14-29. PubMed ID: 25438996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding fuel to the fire: immunogenic intensification.
    O'Sullivan Coyne G; Gulley JL
    Hum Vaccin Immunother; 2014; 10(11):3306-12. PubMed ID: 25483630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
    Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
    Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy Targeting WT1: Designing a Protocol for WT1 Peptide-Based Cancer Vaccine.
    Nishida S; Sugiyama H
    Methods Mol Biol; 2016; 1467():221-32. PubMed ID: 27417973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines and melanoma.
    Ott PA; Fritsch EF; Wu CJ; Dranoff G
    Hematol Oncol Clin North Am; 2014 Jun; 28(3):559-69. PubMed ID: 24880947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.